ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NTY Nabriva Therapeutics Plc

0.00
0.00 (0.00%)
- - Closed
Realtime Data
Share Name Share Symbol Market Type
Nabriva Therapeutics Plc TG:NTY Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

NBTY Announces Preliminary Net Sales Results for December and Fiscal First Quarter

12/01/2010 12:00pm

PR Newswire (US)


Nabriva Therapeutics (TG:NTY)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Nabriva Therapeutics Charts.
RONKONKOMA, N.Y., Jan. 12 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer and marketer of nutritional supplements, today announced the following preliminary net sales results for the month of December 2009 and the fiscal first quarter ended December 31, 2009. NBTY's preliminary unaudited net sales results for the month of December 2009 by segment are as follows: NET SALES (Preliminary and Unaudited) FOR THE MONTH OF DECEMBER ($ In Millions) 2009 2008 % Change ---- ---- -------- Wholesale / US Nutrition $176 $156 13% North American Retail $18 $17 4% European Retail $59 $53 12% Direct Response / E-Commerce $16 $15 11% --- --- --- Total $269 $241 12% North American Retail same store sales increased 2% for the one month period of December 2009 compared to December 2008. European Retail same store sales were unchanged and total European Retail net sales for the month of December 2009 increased 3% in local currency (British Pound Sterling). NBTY's preliminary unaudited net sales results for the fiscal first quarter ended December 31, 2009 by segment are as follows: NET SALES (Preliminary and Unaudited) FOR THE FISCAL FIRST QUARTER ENDED DECEMBER 31 ($ In Millions) 2009 2008 % Change ---- ---- -------- Wholesale / US Nutrition $471 $407 16% North American Retail $51 $48 6% European Retail $176 $156 13% Direct Response / E-Commerce $53 $49 7% --- --- --- Total $751 $661 14% North American Retail same store sales increased 4% for the fiscal first quarter ended December 31, 2009, compared to the prior like quarter. European Retail same store sales increased 6% and total European Retail net sales increased 8% for fiscal first quarter ended December 31, 2009, in local currency (British Pound Sterling). ABOUT NBTY NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 25,000 products, including products marketed by the Company's Nature's Bounty(R) (http://www.naturesbounty.com/), Vitamin World(R) (http://www.vitaminworld.com/), Puritan's Pride(R) (http://www.puritan.com/), Holland & Barrett(R) (http://www.hollandandbarrett.com/), Rexall(R) (http://www.rexall.com/), Sundown(R) (http://www.sundownnutrition.com/), MET-Rx(R) (http://www.metrx.com/), Worldwide Sport Nutrition(R) (http://www.sportnutrition.com/), American Health(R) (http://www.americanhealthus.com/), GNC (UK)(R) (http://www.gnc.co.uk/), DeTuinen(R) (http://www.detuinen.nl/), LeNaturiste(TM) (http://www.lenaturiste.com/), SISU (R) (http://www.sisu.com/), Solgar(R) (http://www.solgar.com/), Good 'n' Natural(R) (http://www.goodnnatural.com/), Home Health(TM) (http://www.homehealthus.com/), Julian Graves, and Ester-C (R)(http://www.ester-c.com/) brands. NBTY routinely posts information that may be important to investors on its web site. Contact: Harvey Kamil Carl Hymans NBTY, Inc. G.S. Schwartz & Co. President & Chief Financial Officer 212-725-4500 631-200-2020 DATASOURCE: NBTY, Inc. CONTACT: Harvey Kamil, NBTY, Inc., President & Chief Financial Officer, +1-631-200-2020; or Carl Hymans, G.S. Schwartz & Co., +1-212-725-4500, Web Site: http://www.nbty.com/

Copyright

1 Year Nabriva Therapeutics Chart

1 Year Nabriva Therapeutics Chart

1 Month Nabriva Therapeutics Chart

1 Month Nabriva Therapeutics Chart

Your Recent History

Delayed Upgrade Clock